63 related articles for article (PubMed ID: 28657695)
1. Rare PDCD11 variations are not associated with risk of schizophrenia in Japan.
Hoya S; Watanabe Y; Hishimoto A; Nunokawa A; Kaneko N; Muratake T; Shinmyo N; Otsuka I; Okuda S; Inoue E; Igeta H; Shibuya M; Egawa J; Orime N; Sora I; Someya T
Psychiatry Clin Neurosci; 2017 Nov; 71(11):780-788. PubMed ID: 28657695
[TBL] [Abstract][Full Text] [Related]
2. Rare UNC13B variations and risk of schizophrenia: Whole-exome sequencing in a multiplex family and follow-up resequencing and a case-control study.
Egawa J; Hoya S; Watanabe Y; Nunokawa A; Shibuya M; Ikeda M; Inoue E; Okuda S; Kondo K; Saito T; Kaneko N; Muratake T; Igeta H; Iwata N; Someya T
Am J Med Genet B Neuropsychiatr Genet; 2016 Sep; 171(6):797-805. PubMed ID: 26990377
[TBL] [Abstract][Full Text] [Related]
3. Rare FBXO18 variations and risk of schizophrenia: Whole-exome sequencing in two parent-affected offspring trios followed by resequencing and case-control studies.
Hoya S; Watanabe Y; Hishimoto A; Nunokawa A; Inoue E; Igeta H; Otsuka I; Shibuya M; Egawa J; Sora I; Someya T
Psychiatry Clin Neurosci; 2017 Aug; 71(8):562-568. PubMed ID: 28317220
[TBL] [Abstract][Full Text] [Related]
4. Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese population.
Watanabe Y; Nunokawa A; Shibuya M; Ikeda M; Hishimoto A; Kondo K; Egawa J; Kaneko N; Muratake T; Saito T; Okazaki S; Shimasaki A; Igeta H; Inoue E; Hoya S; Sugai T; Sora I; Iwata N; Someya T
Psychiatry Res; 2016 Jan; 235():13-8. PubMed ID: 26706132
[TBL] [Abstract][Full Text] [Related]
5. Rare compound heterozygous missense
Igeta H; Watanabe Y; Morikawa R; Ikeda M; Otsuka I; Hoya S; Koizumi M; Egawa J; Hishimoto A; Iwata N; Someya T
Neuropsychiatr Dis Treat; 2019; 15():2353-2363. PubMed ID: 31695380
[TBL] [Abstract][Full Text] [Related]
6. Novel rare missense variations and risk of autism spectrum disorder: whole-exome sequencing in two families with affected siblings and a two-stage follow-up study in a Japanese population.
Egawa J; Watanabe Y; Wang C; Inoue E; Sugimoto A; Sugiyama T; Igeta H; Nunokawa A; Shibuya M; Kushima I; Orime N; Hayashi T; Okada T; Uno Y; Ozaki N; Someya T
PLoS One; 2015; 10(3):e0119413. PubMed ID: 25806950
[TBL] [Abstract][Full Text] [Related]
7. Rare heterozygous truncating variations and risk of autism spectrum disorder: Whole-exome sequencing of a multiplex family and follow-up study in a Japanese population.
Inoue E; Watanabe Y; Egawa J; Sugimoto A; Nunokawa A; Shibuya M; Igeta H; Someya T
Psychiatry Clin Neurosci; 2015 Aug; 69(8):472-6. PubMed ID: 25601189
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing in a family with a monozygotic twin pair concordant for schizophrenia and a follow-up case-control study of identified de-novo variants.
Hoya S; Watanabe Y; Nunokawa A; Otsuka I; Shibuya M; Igeta H; Hishimoto A; Someya T
Psychiatr Genet; 2020 Apr; 30(2):60-63. PubMed ID: 32106127
[TBL] [Abstract][Full Text] [Related]
9. Novel missense SETD1A variants in Japanese patients with schizophrenia: Resequencing and association analysis.
Morikawa R; Watanabe Y; Igeta H; Arta RK; Ikeda M; Okazaki S; Hoya S; Saito T; Otsuka I; Egawa J; Tanifuji T; Iwata N; Someya T
Psychiatry Res; 2022 Apr; 310():114481. PubMed ID: 35235885
[TBL] [Abstract][Full Text] [Related]
10. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families.
Timms AE; Dorschner MO; Wechsler J; Choi KY; Kirkwood R; Girirajan S; Baker C; Eichler EE; Korvatska O; Roche KW; Horwitz MS; Tsuang DW
JAMA Psychiatry; 2013 Jun; 70(6):582-90. PubMed ID: 23553203
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
[TBL] [Abstract][Full Text] [Related]
12. PICK1 is not a susceptibility gene for schizophrenia in a Japanese population: association study in a large case-control population.
Ishiguro H; Koga M; Horiuchi Y; Inada T; Iwata N; Ozaki N; Ujike H; Muratake T; Someya T; Arinami T
Neurosci Res; 2007 Jun; 58(2):145-8. PubMed ID: 17367885
[TBL] [Abstract][Full Text] [Related]
13. No association of CNR1 gene variations with susceptibility to schizophrenia.
Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome sequencing of monozygotic twins discordant for schizophrenia indicates multiple genetic risk factors for schizophrenia.
Tang J; Fan Y; Li H; Xiang Q; Zhang DF; Li Z; He Y; Liao Y; Wang Y; He F; Zhang F; Shugart YY; Liu C; Tang Y; Chan RCK; Wang CY; Yao YG; Chen X
J Genet Genomics; 2017 Jun; 44(6):295-306. PubMed ID: 28645778
[TBL] [Abstract][Full Text] [Related]
15. Novel polymorphisms of the AP-2 gene (6p24): analysis of association with schizophrenia.
Kawanishi Y; Harada S; Tachikawa H; Okubo T; Shiraishi H
J Hum Genet; 2000; 45(1):24-30. PubMed ID: 10697959
[TBL] [Abstract][Full Text] [Related]
16. Resequencing of the vesicular glutamate transporter 2 gene (VGLUT2) reveals some rare genetic variants that may increase the genetic burden in schizophrenia.
Shen YC; Liao DL; Lu CL; Chen JY; Liou YJ; Chen TT; Chen CH
Schizophr Res; 2010 Aug; 121(1-3):179-86. PubMed ID: 20541370
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1 beta gene and risk of schizophrenia: detailed case-control and family-based studies and an updated meta-analysis.
Shibuya M; Watanabe Y; Nunokawa A; Egawa J; Kaneko N; Igeta H; Someya T
Hum Psychopharmacol; 2014 Jan; 29(1):31-7. PubMed ID: 24155145
[TBL] [Abstract][Full Text] [Related]
18. Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: a three-stage case-control association study.
Amagane H; Watanabe Y; Kaneko N; Nunokawa A; Muratake T; Ishiguro H; Arinami T; Ujike H; Inada T; Iwata N; Kunugi H; Sasaki T; Hashimoto R; Itokawa M; Ozaki N; Someya T
Schizophr Res; 2010 May; 118(1-3):106-12. PubMed ID: 20188514
[TBL] [Abstract][Full Text] [Related]
19. Genetic and functional analysis of the gene encoding GAP-43 in schizophrenia.
Shen YC; Tsai HM; Cheng MC; Hsu SH; Chen SF; Chen CH
Schizophr Res; 2012 Feb; 134(2-3):239-45. PubMed ID: 22138049
[TBL] [Abstract][Full Text] [Related]
20. Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility.
Kushima I; Nakamura Y; Aleksic B; Ikeda M; Ito Y; Shiino T; Okochi T; Fukuo Y; Ujike H; Suzuki M; Inada T; Hashimoto R; Takeda M; Kaibuchi K; Iwata N; Ozaki N
Schizophr Bull; 2012 May; 38(3):552-60. PubMed ID: 21041834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
